Category: Uncategorized
-
Openings at ip fray: we are hiring (full-time or part-time) — and we are receptive to guest articles (op-eds, insight, just not advertorials)
To grow further, ip fray is looking for top-notch talent, above the level of what web publishers would normally be looking for. And we are more open to guest articles than many people think.
-
UPC starts development of case law on damages causation and quantification, applying German as well as alternatively EU/UPC statutes
In an outlier case where the UPC was asked to determine damages based on a German merits ruling, the panel was unconvinced of any damages being attributable to the defendant’s infringement as opposed to other causes.
-
An interview with bioMérieux IP head Dr. James Robertson
James Robertson, the in vitro diagnostics company’s global head of IP, talked to ip fray about its activities in the Unified Patent Court and some of the successes and hurdles he has experienced since moving from pharma into diagnostics IP management.
-
UK court joins UPC Mannheim in Amazon-Interdigital de-escalation pending appeal — but UK-UPC peace is fragile given what was said today
All eyes are now on the UPC CoA, but the UK court would actually like InterDigital to concede the appeal.
-
Nokia pulls a Huawei against Warner Bros. Discovery, Paramount: prepared to grant interim license
This now the second interim-license case (actually, a pair of cases) in which a SEP holder turns an implementer-filed UK FRAND action into a boomerang.
-
Adeia: new Microsoft patent licensing deal, Q4 2025 revenue hit record $182.6 million
The U.S. licensing firm, which signed 26 agreements in 2025, has started 2026 with strong momentum, signing a patent licensing agreement with Microsoft and reducing its debt by $60 million.
-
Novo Nordisk targets Canadian pharma giant Apotex in new oral semaglutide patent infringement suit
Novo Nordisk has sued Canada’s Apotex in the United States District Court for the District of New Jersey over the alleged infringement of six patents related to its oral weightloss drug Rybelsus.
-
Hisense, Corning settle UPC patent infringement dispute
Corning, which has become a key player in the global AI chip market, has settled its glass patent infringement dispute against Hisense in the Unified Patent Court, while its parallel case in the U.S. International Trade Commission and against TCL continues.
-
“Beyond a simple balance sheet figure”: How a med tech start-up leveraged its patents to raise over €5 million
Med tech start-up Virtonomy and counsel from Bardehle Pagenberg reveal how they leveraged its patent portfolio to close a Series A financing round raising more than €5 million.